384 related articles for article (PubMed ID: 30957958)
41. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
[TBL] [Abstract][Full Text] [Related]
42. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of α, β-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloid β-induced cytotoxicity.
Bukhari SN; Jantan I; Masand VH; Mahajan DT; Sher M; Naeem-ul-Hassan M; Amjad MW
Eur J Med Chem; 2014 Aug; 83():355-65. PubMed ID: 24980117
[TBL] [Abstract][Full Text] [Related]
44. Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: In vitro and in vivo biological evaluation and docking study.
Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Edraki N; Sharifzadeh M; Khanavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():303-316. PubMed ID: 30396115
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
46. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Wang H; Ma Q; Han X; Ye M; Yu L; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5046-5052. PubMed ID: 29033233
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and anticholinesterase activity of coumarin-3-carboxamides bearing tryptamine moiety.
Ghanei-Nasab S; Khoobi M; Hadizadeh F; Marjani A; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Oct; 121():40-46. PubMed ID: 27214510
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and biological evaluation of novel deoxyvasicinone-indole as multi-target agents for Alzheimer's disease.
Nerella A; Jeripothula M
Bioorg Med Chem Lett; 2021 Oct; 49():128212. PubMed ID: 34153471
[TBL] [Abstract][Full Text] [Related]
50. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
Chakravarty H; Ju Y; Chen WH; Tam KY
Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
[TBL] [Abstract][Full Text] [Related]
51. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
[TBL] [Abstract][Full Text] [Related]
52. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
53. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
[TBL] [Abstract][Full Text] [Related]
54. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
56. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties.
Guzior N; Bajda M; Skrok M; Kurpiewska K; Lewiński K; Brus B; Pišlar A; Kos J; Gobec S; Malawska B
Eur J Med Chem; 2015 Mar; 92():738-49. PubMed ID: 25621991
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
Su T; Xie S; Wei H; Yan J; Huang L; Li X
Bioorg Med Chem; 2013 Sep; 21(18):5830-40. PubMed ID: 23932451
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents.
Yun Y; Yang J; Miao Y; Wang X; Sun J
Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295
[TBL] [Abstract][Full Text] [Related]
59. Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.
Ozadali-Sari K; Tüylü Küçükkılınç T; Ayazgok B; Balkan A; Unsal-Tan O
Bioorg Chem; 2017 Jun; 72():208-214. PubMed ID: 28478328
[TBL] [Abstract][Full Text] [Related]
60. A novel 7-O-modified genistein derivative with acetylcholinesterase inhibitory effect, estrogenic activity and neuroprotective effect.
Shi DH; Yan ZQ; Zhang LN; Wang YR; Jiang CP; Wu JH
Arch Pharm Res; 2012 Sep; 35(9):1645-54. PubMed ID: 23054722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
